Determining stability of stored samples retrospectively: The validation of glycated albumin

Clinical Chemistry

Volumn 57, Issue 2, 2011, Pages 286-290

  Nathan, David M ^a   Steffes, Michael W ^b   Sun, Wanjie ^c   Rynders, Gregory P ^b   Lachin, John M ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PROTEIN STABILITY; REGRESSION ANALYSIS; VALIDATION STUDY;

BLOOD SPECIMEN COLLECTION; CLINICAL TRIALS AS TOPIC; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; TIME FACTORS;

EID: 79551472028     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.150250     Document Type: Article

References (11)

1. Diabetes Control and Complications Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. N Engl J Med 1993;329:978-86.
2. Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-9.
3. Steffes M, Cleary P, Goldstein D, Little R, Wiedemeyer HM, Rohlfing C, et al. Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. Clin Chem 2005;51:753-8.
4. Nagamine Y, Mitsui K, Nakao T, Matsumoto M, Fujita C, Doi T. Evaluation of the enzymatic method for glycated albumin with liquid type reagent (Lucia GA-L) [in Japanese]. Jpn J Med Pharm Sci 2004;51:737-45.
5. Diabetes Control and Complications Research Group. The association between glycemic exposure and long-term diabetic complications in the Diabetes Control and Complications Trial. Diabetes 1995;44:968-83.
6. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN for the DCCT/EDIC Research Group. The effect of glycemic exposure on the risk of microvascular complications in the Diabetes Control and Complications Trial - Revisited. Diabetes 2008;57:995-1001.
7. EDIC Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC): Design and implementation of a long-term follow-up of the Diabetes Control and Complications Trial Cohort. Diabetes Care 1999;22:99-111.
8. Goldstein DE, Soeldner S, Cleary PA, Nathan DM. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial (DCCT): a multicenter trial. Clin Chem 1987;33:2267-71.
9. Yoshiuchi K, Matsuhisa M, Kakatami N, Nakatani Y, Sakamoto K, Matsuoka T, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008;55:503-7.
10. Selvin E, Coresh J, Jordahl J, Boland L, Steffes MW. Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade. Diabet Med 2005;22:1726-30.
11. Bodnar LM, Catov JM, Wisner KL, Klebanoff MA: Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr 2008;23:1-7.